AKEEGA 100 mg/500 mg, comprimé pelliculé — plaquette(s) PVDC polyéthylène PVC aluminium de 56 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930271247
  • CIP7 3027124
  • CIS 69324990
  • Registration number EU/1/23/1722

What the source publishes

Holder
JANSSEN CILAG INTERNATIONAL NV
Active ingredients
TOSYLATE DE NIRAPARIB MONOHYDRATÉ, ACÉTATE D'ABIRATÉRONE, ABIRATÉRONE, NIRAPARIB
Form
comprimé pelliculé
Package
plaquette(s) PVDC polyéthylène PVC aluminium de 56 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
Marketing status
Déclaration de commercialisation
Authorised on
2023-04-19
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930271247
{
  "cis": "69324990",
  "cip7": "3027124",
  "form": "comprimé pelliculé",
  "name": "AKEEGA 100 mg/500 mg, comprimé pelliculé — plaquette(s) PVDC polyéthylène PVC aluminium de 56 comprimé(s)",
  "cip13": "3400930271247",
  "holder": "JANSSEN CILAG INTERNATIONAL NV",
  "routes": [
    "orale"
  ],
  "holders": [
    "JANSSEN CILAG INTERNATIONAL NV"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": null,
  "authorisedOn": "2023-04-19",
  "compositions": [
    {
      "name": "TOSYLATE DE NIRAPARIB MONOHYDRATÉ",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "19651",
      "dosageReference": null,
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "ACÉTATE D'ABIRATÉRONE",
      "nature": "SA",
      "strength": "500 mg",
      "linkageNumber": "2",
      "substanceCode": "37304",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "ABIRATÉRONE",
      "nature": "FT",
      "strength": "446 mg",
      "linkageNumber": "2",
      "substanceCode": "76107",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "NIRAPARIB",
      "nature": "FT",
      "strength": "100 mg",
      "linkageNumber": "1",
      "substanceCode": "82705",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
  "dispensingFee": null,
  "medicinePrice": null,
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "AKEEGA 100 mg/500 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquette(s) PVDC polyéthylène PVC aluminium de 56 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [],
  "marketingDeclaredOn": "2023-08-14",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "TOSYLATE DE NIRAPARIB MONOHYDRATÉ",
    "ACÉTATE D'ABIRATÉRONE",
    "ABIRATÉRONE",
    "NIRAPARIB"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
    "prescription hospitalière",
    "liste I",
    "prescription réservée aux médecins compétents en CANCEROLOGIE"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/23/1722",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930271247"